Allergy Therapeutics plc (AIM:AGY)
5.40
-0.58 (-9.70%)
Jul 27, 2026, 4:35 PM GMT
Allergy Therapeutics Financials Overview
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 57.29 | 55.04 | 55.2 | 59.59 | 72.77 | 84.33 |
Revenue Growth | 4.09% | -0.28% | -7.36% | -18.11% | -13.71% | 7.83% |
Gross Profit Gross Profit Growth | 29.92 | 29.3 | 29.74 | 33.25 | 49.51 | 62.23 |
Operating Income Operating Income Growth | -30.93 | -28.16 | -35.26 | -39.65 | -12.25 | 4.03 |
Net Income Net Income Growth | -48.97 | -40.13 | -38.62 | -43.07 | -13.78 | 2.89 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.06 | -0.02 | 0.00 |
EPS Growth | - | - | - | - | - | -59.05% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Germany Germany Growth | 26.69 | 27.3 | 31.76 | 42.58 | 53.8 |
Austria Austria Growth | 5.26 | 4.95 | 4.9 | 5.23 | 5.6 |
Netherlands Netherlands Growth | 3.96 | 4.06 | 4.02 | 4.28 | 4.17 |
Switzerland Switzerland Growth | 2.34 | 2.86 | 2.84 | 3.3 | 3.14 |
Italy Italy Growth | 2.87 | 3.07 | 3.05 | 3.4 | 3.97 |
Spain Spain Growth | 9.6 | 8.88 | 9.38 | 8.87 | 8.42 |
Other Southern Europe Other Southern Europe Growth | 0.2 | 0.37 | 0.4 | 0.56 | 0.53 |
Inter Segment Inter Segment Growth | -30.63 | -30.41 | -28.73 | -39.37 | -53.98 |
Rest of World (Including UK) Rest of World (Including UK) Growth | 34.78 | 34.12 | 31.98 | 43.92 | 58.68 |
Total Total Growth | 55.04 | 55.2 | 59.59 | 72.77 | 84.33 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 10.08 | 12.79 | 12.92 | 14.85 | 20.52 | 40.27 |
Total Debt Total Debt Growth | 26.75 | 60.09 | 30.99 | 35.99 | 10.53 | 11.17 |
Net Cash (Debt) Net Cash Growth | -16.67 | -47.3 | -18.07 | -21.14 | 9.99 | 29.1 |
Net Cash Growth | - | - | - | - | -65.69% | 17.42% |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.01 | -0.00 | -0.03 | 0.02 | 0.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -32.16 | -28.11 | -32.14 | -28.88 | -14 | 8.59 |
Capital Expenditures CapEx Growth | -4.55 | -3.26 | -3.4 | -4.67 | -3.06 | -2.56 |
Free Cash Flow Free Cash Flow Growth | -36.71 | -31.37 | -35.54 | -33.55 | -17.06 | 6.03 |
Free Cash Flow Growth | - | - | - | - | - | -41.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 52.22% | 53.23% | 53.87% | 55.79% | 68.03% | 73.79% |
Operating Margin | -53.98% | -51.16% | -63.87% | -66.55% | -16.83% | 4.78% |
Pretax Margin | -82.33% | -71.22% | -70.95% | -70.09% | -17.39% | 4.34% |
Profit Margin | -85.46% | -72.91% | -69.97% | -72.28% | -18.93% | 3.42% |
FCF Margin | -64.07% | -57.00% | -64.38% | -56.30% | -23.44% | 7.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | - | - | - | 58.14 |
Forward PE | - | 63.31 | 63.31 | 63.31 | 63.31 | 63.31 |
P/FCF Ratio | - | - | - | - | - | 26.62 |
PS Ratio | 5.97 | 6.88 | 4.52 | 0.12 | 1.84 | 1.90 |